The grant of the Executive Options is subject to the Company obtaining prior
shareholder approval which will be sought at the Company’s 2019 annual general
meeting. The annual general meeting is to be held on or before 13 December 2019
pursuant to an extension granted by the Australian Securities & Investments
Commission. Please see the Company’s announcement of 30 October 2019 (‘Aurora
AGM to be held on 13 December 2019’).
- Forums
- ASX - By Stock
- Ann: Change to Remuneration Package of Managing Director
The grant of the Executive Options is subject to the Company...
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A3D (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.7¢ |
Change
0.002(2.67%) |
Mkt cap ! $28.30M |
Open | High | Low | Value | Volume |
7.6¢ | 7.8¢ | 7.4¢ | $99.22K | 1.308M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 48237 | 7.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.7¢ | 274548 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 48237 | 0.074 |
1 | 142857 | 0.070 |
2 | 609326 | 0.069 |
1 | 34000 | 0.064 |
1 | 61241 | 0.063 |
Price($) | Vol. | No. |
---|---|---|
0.077 | 274548 | 2 |
0.078 | 177157 | 2 |
0.079 | 47000 | 1 |
0.080 | 26455 | 3 |
0.084 | 100000 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
A3D (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online